(Q35764580)

10 August 2017

1 reference

title

153Sm-EDTMP for bone pain palliation in skeletal metastases (English)

1 reference

samarium (153sm) lexidronam

10 August 2017

main subject

1 reference

Carlo L Maini

1

1 reference

10 August 2017

Serenella Bergomi

series ordinal

2

1 reference

10 August 2017

Luisa Romano

series ordinal

3

1 reference

10 August 2017

Rosa Sciuto

series ordinal

4

1 reference

10 August 2017

publication date

4 May 2004

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

10 August 2017

published in

1 reference

10 August 2017

volume

31 Suppl 1

1 reference

10 August 2017

page(s)

S171-8

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-004-1540-y

10 August 2017

exact match

0 references

cites work

Radiation absorbed dose calculations for samarium-153-EDTMP localized in bone

1 reference

12 December 2020

Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone

1 reference

12 December 2020

Future directions for unsealed source radionuclide therapy for bone metastases

1 reference

12 December 2020

A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonate

1 reference

12 December 2020

A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.

1 reference

12 December 2020

Samarium Sm-153 lexidronam for the palliation of bone pain associated with metastases

1 reference

12 December 2020

Radiopharmaceuticals in clinical trials

1 reference

12 December 2020

Therapy of metastatic bone pain

1 reference

12 December 2020

Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial

1 reference

12 December 2020

Samarium-153-EDTMP bone uptake rate and its relation to therapeutic effect

1 reference

12 December 2020

Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer

1 reference

12 December 2020

Radionuclide therapy with bone seeking radionuclides in palliation of painful bone metastases

1 reference

12 December 2020

Samarium-153-EDTMP biodistribution and dosimetry estimation

1 reference

12 December 2020

Short- and long-term effects of 186Re-1,1-hydroxyethylidene diphosphonate in the treatment of painful bone metastases.

1 reference

12 December 2020

Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases

1 reference

12 December 2020

Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer

1 reference

12 December 2020

Samarium-153 EDTMP therapy of disseminated skeletal metastasis

1 reference

12 December 2020

Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?

1 reference

12 December 2020

Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89

1 reference

12 December 2020

Samarium-153-EDTMP in bone metastases.

1 reference

12 December 2020

The clinical course of bone metastases from breast cancer

1 reference

12 December 2020

Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China.

1 reference

12 December 2020

Skeletal localization of samarium-153 chelates: potential therapeutic bone agents.

1 reference

12 December 2020

Mechanisms of osteolytic bone metastases in breast carcinoma

1 reference

12 December 2020

Evaluation of efficacy of 153Sm-EDTMP in patients with painful bone metastases of breast cancer

1 reference

12 December 2020

Bisphosphonates and radiation therapy for palliation of metastatic bone disease

1 reference

12 December 2020

Platinum compounds as radiosensitizers in strontium-89 metabolic radiotherapy

1 reference

12 December 2020

Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.

1 reference

12 December 2020

Bisphosphonates and breast carcinoma: present and future

1 reference

12 December 2020

Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153Samarium-EDTMP

1 reference

12 December 2020

Unsealed source therapy of painful bone metastases: an update

1 reference

12 December 2020

Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.

1 reference

12 December 2020

Measurement of Pain and Analgesia in Cancer Patients

1 reference

12 December 2020

Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients

1 reference

12 December 2020

A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186(Sn)-HEDP.

1 reference

12 December 2020

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial

1 reference

12 December 2020

Bone metastases in breast cancer patients

1 reference

12 December 2020

Radiation dose calculations in persons receiving injection of samarium-153 EDTMP.

1 reference

12 December 2020

Current status of systemic intravenous radiopharmaceuticals for the treatment of painful metastatic bone disease.

1 reference

12 December 2020

Radiotherapy for bone pain

1 reference

12 December 2020

A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases

1 reference

12 December 2020

10.1007/S00259-004-1540-Y

Identifiers

DOI

1 reference

10 August 2017

1 reference